-+ 0.00%
-+ 0.00%
-+ 0.00%

CureVac Q4 Sales €14.50M May Not Be Comparable To €6.50M Estimate

Benzinga·04/10/2025 11:33:02
Listen to the news
CureVac (NASDAQ:CVAC) reported quarterly sales of $14.50 million which beat the analyst consensus estimate of $6.50 million by 123.08 percent. This is a 35.84 percent decrease over sales of $22.60 million the same period last year.